Decisions of the Annual General Meeting of CapMan Plc

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
61
Decisions of the Annual General Meeting of CapMan Plc

CapMan Plc Stock Exchange Release    15 March 2017 at 12.00 p.m. EET

Decisions of the Annual General Meeting of CapMan Plc

The Annual General Meeting (AGM) of CapMan Plc was held today in Helsinki. The AGM approved the annual accounts for the financial year 2016 and discharged the company's directors from liability. The AGM approved all the proposals of the Board of Directors to the AGM.

Use of the profit shown on the balance sheet and payment of dividend

The Annual General Meeting decided, in accordance with the proposal of the Board of Directors, that a dividend of EUR 0.09 per share be paid from the distributable assets of CapMan Plc. The dividend will be paid to shareholders who on the dividend record date 17 March 2017 are recorded in the company's shareholders' register held by Euroclear Finland Ltd. The dividend will be paid on 3 April 2017.

Election and remuneration of the members of the Board of Directors

The Annual General Meeting decided that the Board of Directors comprises five (5) members. Mr. Karri Kaitue, Ms. Nora Kerppola, Mr. Ari Tolppanen, Ms.  Mammu Kaario and Mr. Andreas Tallberg were elected members of the Board of Directors for a term of office expiring at the end of the next Annual General Meeting.

The following monthly remuneration shall be paid to the members of the Board of Directors: EUR 4,000 to the Chairman, EUR 3,200 to the Vice Chairman and EUR 2,800 to the other members of the Board of Directors. Approximately 40 per cent of the total amount of the monthly remuneration will be paid in CapMan Plc's shares purchased at a price formed in public trading and 60 per cent of the total amount of the monthly remuneration will be paid in cash. The shares will be purchased within two weeks from the release of the company's interim report 1 January-31 March 2017 and the company will cover the possible transfer tax. The members of the Board of Directors shall retain until the end of their Board membership the shares they have received as Board remuneration. Furthermore, for participation in meetings of the Board of Directors and Committees of the Board of Directors, the Chairmen of the Board and Board's Committees are paid a meeting fee of EUR 800 per meeting and the members of the Board and Board's Committees are paid a meeting fee of EUR 400 per meeting in addition to their monthly remuneration. The travel expenses of the members of the Board of Directors are compensated in accordance with the company's travel compensation policy.

Election and remuneration of the auditor

PricewaterhouseCoopers Oy, authorised public accountants, was re-elected auditor of the company. PricewaterhouseCoopers Oy has notified the company that Mr. Lauri Kallaskari, APA, will continue to act as the lead auditor. The auditor's term of office shall expire at the end of the next Annual General Meeting. It was decided that the remuneration to the auditor shall be paid and travel expenses compensated against the auditor's reasonable invoice.

Authorising the Board of Directors to decide on the repurchase and/or the acceptance as pledge of the company's own shares

The Annual General Meeting authorised the Board of Directors to decide on the repurchase and/or on the acceptance as pledge of the company's own shares as follows:

The amount of own shares to be repurchased and/or accepted as pledge shall not exceed 14,000,000 shares, which corresponds to approximately 9.66 per cent of all shares in the company. Only the unrestricted equity of the company can be used to repurchase own shares on the basis of the authorisation.

Own shares can be repurchased at a price formed in public trading on the date of the repurchase or otherwise at a price formed on the market.

The Board of Directors decides how own shares will be repurchased and/or accepted as pledge. Shares can be repurchased using, inter alia, derivatives. Own shares can be repurchased otherwise than in proportion to the shareholdings of the existing shareholders (directed repurchase).

Own shares may be repurchased on the basis of the authorisation in order to finance or carry out acquisitions or other business transactions, in order to develop the company's capital structure, to improve the liquidity of the company's shares, to be disposed for other purposes or to be cancelled. Own shares may be accepted as pledge on the basis of the authorisation in order to finance or carry out acquisitions or other business transactions. The authorisation cannot be used for incentive schemes.

The authorisation cancels the authorisation given to the Board of Directors by the General Meeting on 16 March 2016 to decide on the repurchase and/or acceptance as pledge of the company's own shares.

The authorisation is effective until the end of the next Annual General Meeting, however no longer than until 30 June 2018.

Authorising the Board of Directors to decide on the issuance of shares as well as the issuance of special rights entitling to shares

The Annual General Meeting authorised the Board of Directors to decide on the issuance of shares and the issuance of special rights entitling to shares referred to in chapter 10, section 1 of the Companies Act as follows:

The amount of shares to be issued shall not exceed 21,000,000 shares, which corresponds to approximately 14.48 per cent of all shares in the company.

The Board of Directors decides on all the conditions of the issuance of shares and of special rights entitling to shares. The issuance of shares and of special rights entitling to shares may be carried out in deviation from the shareholders' pre-emptive rights (directed issue).

The authorisation can be used to finance and to carry out acquisitions or other business transactions and investments as well as to improve the capital structure. The authorisation cannot be used for incentive schemes.

The authorisation cancels the authorisation given to the Board of Directors by the General Meeting on 16 March 2016 to decide on the issuance of shares as well as the issuance of special rights entitling to shares.

The authorisation is effective until the end of the next Annual General Meeting, however no longer than until 30 June 2018.

Helsinki 15 March 2017

CapMan Plc

Additional information: Pasi Erlin, General Counsel, Tel. +358 207 207 503

DISTRIBUTION Nasdaq Helsinki Ltd Principal media www.capman.com

CapMan www.capman.com CapMan is a leading Nordic investment and specialised asset management company. As one of the Nordic private equity pioneers we have actively developed hundreds of companies and real estate and thereby created substantial value in these businesses and assets over the last 25 years. CapMan has today 100 private equity professionals and manages €2.8 billion in assets. We mainly manage the assets of our customers, the investors, but also make direct investments from our own balance sheet in areas without an active fund. Our objective is to provide attractive returns and innovative solutions to investors and value adding services to professional investment partnerships, growth-oriented companies and tenants. Our current investment strategies cover Buyout, Growth Equity, Real Estate, Russia, Credit, Infrastructure and Tactical Opportunities. We also have a growing service business that currently includes fundraising advisory, procurement activities and fund management.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Smart Banner Choices: Decisions Beyond Design

Updated Category News Views 152

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 37

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 146

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Updated Category News Views 96

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

Continue Reading
APEC Summit 2026: Shenzhen in the Spotlight

Updated Category News Views 58

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Continue Reading
Endava Faces Class Action: Investor Reactions and Next Steps

Updated Category News Views 72

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

Continue Reading
First Horizon's $25M Bet: New Center Transforms Houston

Updated Category News Views 76

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 58

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening Heart and Kidney Health Through Collaboration

Updated Category News Views 264

Collaboration for Health Awareness In an exciting development, the American Kidney Fund (AKF) has forged a partnership with the American Heart Association (AHA) as part of their Cardiovascular-Kidney-Metabolic Health Initiative™. This collaboration aims to raise awareness regarding the crucial link between kidney disease and cardiovascular conditions, both of which...

Continue Reading
Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown

Updated Category News Views 106

Kering Faces Challenges Amid Analyst Downgrades and Market Slowdown Kering (EPA: PRTP) has recently experienced a shift in market sentiment as analysts express increasing caution regarding its performance. TD Cowen has notably lowered its price target for Kering to €230 from €260, while sustaining a Hold rating for the stock. The adjustment signals growing concerns...

Continue Reading
Xi Jinping Champions Common Development at G20 Summit

Updated Category News Views 308

Xi Jinping's Vision for Global Cooperation at the G20 Summit Chinese President Xi Jinping recently made headlines during a significant gathering known as the G20 Summit. His participation underscored a strong commitment to fostering global cooperation and development, marking a notable moment in international relations. Advocating for a Unified Approach During his...

Continue Reading
OHA Secures Financing for Onex's Acquisition of Farsound

Updated Category News Views 84

OHA Leads Innovative Financing for Strategic Acquisition In a significant development in the financial world, Oak Hill Advisors (OHA) has taken on the role of Lead Left Arranger for a private unitranche financing aimed at supporting the acquisition of Farsound Aviation Limited by Onex. Farsound stands out in the aerospace engine maintenance, repair, and overhaul (MRO)...

Continue Reading
Zentalis Pharmaceuticals Rebounds After FDA Clearance for Azenosertib

Updated Category News Views 75

Zentalis Pharmaceuticals Advances with Azenosertib Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), located in San Diego, has some exciting updates for its stakeholders. The U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on the company's studies involving azenosertib. This is fantastic news, as it enables Zentalis to restart patient enrollment...

Continue Reading